Unlock instant, AI-driven research and patent intelligence for your innovation.

A kind of pharmaceutical composition for treating diabetes and its preparation method

A composition and diabetes technology, applied in the field of medicine, can solve problems such as incomplete understanding, lack of treatment methods for etiology, complex etiology and pathogenesis, and achieve high total effective rate, no toxic and side effects, and high bioavailability Effect

Active Publication Date: 2015-11-25
QIDONG CIYT XINZAO CASTING FACTORY
View PDF1 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Moreover, the etiology and pathogenesis of this disease are complicated and have not been fully understood so far, and there is even a lack of effective methods for treating the etiology.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0024] A pharmaceutical composition for treating diabetes, which is prepared from the following raw materials: 28 parts of Atractylodes macrocephala, 28 parts of Polyporus, 25 parts of white lentils, 25 parts of purslane, 24 parts of Fructus aurantii, 22 parts of bark of Albizia juniper, Radix Ophiopogon japonicus 20 parts, 20 parts of yam, 18 parts of radish, 18 parts of angelica, 15 parts of mulberry leaves, 15 parts of Alisma, 15 parts of japonica rice, 12 parts of licorice, 12 parts of trichosanthin, 12 parts of cassia twig, 10 parts of dried ginger, 10 parts of astragalus 10 parts of dogwood, 9 parts of ebony plum, 9 parts of Polygonatum odoratum, 9 parts of peach kernel, 7 parts of kudzu root, 7 parts of rehmannia glutinosa, 5 parts of schisandra, 5 parts of gardenia, 5 parts of Anemarrhena, and 3 parts of melon seeds.

[0025] Its preparation and taking method of the pharmaceutical composition of the present invention are: take the crude drug (proportioning unit: gram) o...

Embodiment 2

[0031] zoology experiment

[0032] Experimental animals: 50 SD rats, half male and half male, weighing 160-180 g, provided by the Animal Center of the First Affiliated Hospital of Shandong University. After the rats were adapted to feeding in the animal room for 5 days, 10 rats were randomly selected as the normal control group and fed with ordinary maintenance feed. High-sugar and high-fat feed formula: rat basic feed 68%, sucrose 10%, egg yolk powder 9%, lard 8%, cholesterol 1%, bile salt 0.2%.

[0033] Implementation method: the remaining 40 were fed with high-sugar and high-fat feed for 4 weeks. After 4 weeks, the rats were fasted for 24 hours, and streptozotocin (STZ) was injected intravenously at 20 mg / Kg, once every two days. Choose 36 successful rats of modeling, be divided into 3 groups at random, every group of 12, i.e. model group (do not use any medicine), the embodiment of the present invention 1 medicine group 10mg / Kg, control medicine group: use metformin hydr...

Embodiment 3

[0040] clinical information:

[0041] Materials and Methods: General information There were 71 outpatients with type 2 diabetes mellitus, including 37 males and 34 females, aged 49-75 years, with significantly elevated fasting blood glucose (FPG) and 2h postprandial blood glucose (2hPG). After taking the medicine prepared in Example 1 of the present invention for two courses of treatment, the above biochemical indicators were detected.

[0042] Cure: FPG<6.1mmol / L, 2h blood glucose (2hPG)<8.0mmol / L;

[0043] Effective: Fasting blood glucose (FPG) and postprandial 2h blood glucose (2hPG) have improved, but have not reached normal levels;

[0044] Ineffective: Fasting blood glucose (FPG) and postprandial 2h blood glucose (2hPG) did not change significantly;

[0045] Treatment effect: 49 cases were cured, 19 cases were effective, and 3 cases were ineffective. The total effective rate was over 95.8%.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to a pharmaceutical composition for treating diabetes mellitus and a preparation method thereof. The pharmaceutical composition is prepared from the following raw materials in parts by weight: 28 parts of white atractylodes rhizome, 28 parts of umbellate pore fungus, 25 parts of white hyacinth bean, 25 parts of herba portulacae, 24 parts of fructus aurantii, 22 parts of cortex albiziae, 20 parts of radix ophiopogonis, 20 parts of Chinese yam, 18 parts of semen raphani, 18 parts of angelica sinensis, 15 parts of folium mori, 15 parts of rhizoma alismatis, 15 parts of polished round-grained rice, 12 parts of liquorice, 12 parts of radices trichosanthis, 12 parts of cassia twig, 10 parts of rhizoma zingiberis, 10 parts of astragalus membranaceus, 10 parts of dogwood, 9 parts of smoked plum, 9 parts of radix polygonati officinalis, 9 parts of peach kernel, 7 parts of root of kudzu vine, 7 parts of prepared rehmannia root, 5 parts of schisandra chinensis, 5 parts of jasmine, 5 parts of rhizoma anemarrhenae and 3 parts of muskmelon seed. The pharmaceutical composition is short in treatment course aiming at the diabetes mellitus, high in total effective rate, not easy to reappear after recovery, and simple in process; the production cost is reduced; the economical burden of a sufferer is reduced.

Description

technical field [0001] The invention belongs to the technical field of medicine, and in particular relates to a pharmaceutical composition for treating diabetes and a preparation method. Background technique [0002] Diabetes is a common endocrine and metabolic disease. Symptoms of diabetic patients include: polydipsia, polyuria, polyphagia, weight loss and other symptoms. In severe cases, ketoacidosis and coma occur. Moreover, diabetes can cause arteriosclerosis and microvascular disease due to long-term high blood sugar, and early and serious heart disease. , brain, kidney, eyes, nerves, skin and other organs are damaged, and symptoms and signs of corresponding organs appear. Diabetes often has corresponding symptoms and signs due to the decline of the body's immunity and defense function, and it is easy to be combined with skin, mucous membrane and soft tissue infectious diseases (furuncle, carbuncle, cellulitis, gangrene), respiratory tract infection (pneumonia, tubercu...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61K36/9068A61K9/48A61P3/10
Inventor 宋仪利李涛王永翠
Owner QIDONG CIYT XINZAO CASTING FACTORY